PT  - JOURNAL ARTICLE
AU  - Azhough, Ramin
AU  - Dashti, Mohammad Reza
AU  - Taher, Sahar
AU  - Jalali, Pooya
TI  - WITHDRAWN: Comparison of the effects of methylene blue with adrenaline and Marcaine with adrenaline on pain control after hemorrhoidectomy
AID  - 10.1101/2023.09.05.23295049
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.09.05.23295049
4099  - http://medrxiv.org/content/early/2023/12/12/2023.09.05.23295049.short
4100  - http://medrxiv.org/content/early/2023/12/12/2023.09.05.23295049.full
AB  - The authors have withdrawn their manuscript owing to Improve the article. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIRCT20190325043107N27Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the research ethics committee of Tabriz University of Medical Sciences and registered in the Iranian Registry of clinical trials with registration number IRCT20190325043107N27 (the full trial protocol can be accessed at: http://www.irct.ir).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes